Home » Topics » Disease categories and therapies » Infection

Infection
RSS

BMS reports results from cefprozil multicenter clinical study in AOM patients

Dec. 10, 1996

U.S. market introduction for novel antifungal formulation

Dec. 10, 1996

Japanese academic researchers isolate new quassinoid compound

Dec. 10, 1996

Pharmacia & Upjohn, McGill University claim antiparasitic MAb

Dec. 9, 1996

Cytovene approved for new indication in U.S.

Dec. 6, 1996

ChemGenics/Wyeth-Ayerst antibacterial drug discovery collaboration

Dec. 6, 1996

New azole antifungal agents described by Zambon

Dec. 4, 1996

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

Lidak reacquires certain rights to Lidakol from BMS

Dec. 2, 1996

Ivermectin approved for use in humans

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...